Scheme 2From: Development of a multi faceted platform containing a tetrazine, fluorophore and chelator: synthesis, characterization, radiolabeling, and immuno-SPECT imagingIEDDA reaction of TCO-NHS and TCO-trastuzumab with 13Back to article page